| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,550 |
11,276 |
$426K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,238 |
3,070 |
$164K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,682 |
3,287 |
$54K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
473 |
466 |
$42K |
| 99490 |
Ccm add 20min |
1,532 |
1,418 |
$7K |
| 90674 |
|
274 |
271 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
184 |
158 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
265 |
261 |
$4K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
46 |
43 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,601 |
1,400 |
$3K |
| 99454 |
|
99 |
93 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
29 |
28 |
$2K |
| 99457 |
|
90 |
85 |
$2K |
| 99483 |
Prolong outpt/office vis |
54 |
54 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
848 |
799 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
169 |
159 |
$860.20 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
51 |
49 |
$773.42 |
| 99406 |
|
101 |
99 |
$582.56 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
15 |
$530.70 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
86 |
74 |
$395.21 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
24 |
$346.07 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
20 |
12 |
$302.30 |
| 99458 |
|
12 |
12 |
$195.28 |
| J2010 |
Injection, lincomycin hcl, up to 300 mg |
12 |
12 |
$102.12 |
| 82962 |
|
27 |
26 |
$71.50 |
| 99453 |
|
13 |
13 |
$63.78 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
41 |
39 |
$48.72 |
| 90756 |
|
22 |
21 |
$45.58 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,698 |
1,484 |
$1.62 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
46 |
44 |
$0.01 |
| 3078F |
|
43 |
42 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
124 |
113 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
12 |
12 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
63 |
59 |
$0.00 |
| 1123F |
|
12 |
12 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
20 |
19 |
$0.00 |
| 1036F |
|
209 |
176 |
$0.00 |
| 3017F |
|
38 |
38 |
$0.00 |
| 3075F |
|
38 |
38 |
$0.00 |
| 3044F |
|
12 |
12 |
$0.00 |
| 3074F |
|
73 |
71 |
$0.00 |
| 3079F |
|
85 |
84 |
$0.00 |